- Advertisement -
EVANSTON, Ill.–(BUSINESS WIRE)–Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicines, today congratulates its scientific co-founder, Professor Chad A. Mirkin, on being awarded the Harvey Prize in Science and Technology. The prestigious…
Click here to view the original article.
